Sector Chart BioCryst Pharmaceuticals, Inc.
Stocks
BCRX
US09058V1035
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
10:18:43 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 8.145 USD | +1.18% |
|
-1.27% | +4.94% |
| 10-05 | Biocryst Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board | CI |
| 10-05 | BioCryst Pharmaceuticals Forms Scientific Advisory Board as R&D Model Evolves | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.06B | - | - | - | ||
| 68.92B | |||||
| 51.9B | |||||
| 48.73B | |||||
| 43.13B | |||||
| 41.48B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
